What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?

    Research output: Contribution to journalArticlepeer-review

    81 Downloads (Pure)

    Abstract

    For drug transport across (i.e., through) an intact biological membrane, two main routes are possible: drugs may cross (i) through the phospholipid bilayer portion of the membrane, and/or (ii) via proteinaceous pores or transporters. Perhaps surprisingly, there is in fact no direct scientific evidence that the first of these takes place at any significant rate because, in the experiments performed to date, it has neither been varied as an independent variable nor measured directly as a dependent variable. Using a standard hypothetico-deductive framework, I assess the intellectual and observable consequences of assuming that, for drugs, phospholipid bilayer diffusion is negligible - 'PBIN' - (i.e., may be neglected, relative to transporter-mediated transmembrane fluxes). Predictions and postdictions of the PBIN hypothesis are not refuted by available experimental evidence.
    Original languageEnglish
    JournalTrends in pharmacological sciences
    Volume36
    Issue number1
    DOIs
    Publication statusPublished - Jan 2015

    Keywords

    • drug transporters
    • lipoidal bilayer diffusion
    • physiologically based pharmacokinetic modelling
    • systems pharmacology

    Fingerprint

    Dive into the research topics of 'What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?'. Together they form a unique fingerprint.

    Cite this